• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC¿ VALVE (MITRAL); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC¿ VALVE (MITRAL); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number E100-29M
Device Problems Patient-Device Incompatibility (2682); Central Regurgitation (4068)
Patient Problems Dyspnea (1816); Endocarditis (1834); Pulmonary Edema (2020)
Event Date 03/15/2024
Event Type  Injury  
Event Description
The article, "transcatheter mitral valve-in-valve explant: lessons learned", was reviewed.The article presented a case study of a 71-year-old male patient with pulmonary edema and decompensation heart failure.It was reported that on an unknown date, a 33mm epic valve was implanted.It was then reported 11 years post-procedure on an unknown date, the patient presented with acute severe mitral regurgitation and pulmonary edema.A decision was made to perform a transcatheter valve-in-valve procedure with a 29mm sapien valve.It was then reported two and a half years post-intervention, the patient developed recurrent bacterial endocarditis.A decision was made to surgically remove both 33mm epic valve with the embedded 29mm sapien valve.A 33mm epic plus valve was then implanted with no adverse patient consequences.The article concluded that mitral valve-in-valve explant is technically feasible.The authors recommended en bloc removal of both valves as the safest method of valve explant.[the primary and corresponding author was mohammad bashir, university of iowa carver college of medicine, department of cardiothoracic surgery, iowa city, iowa 52242, with corresponding email: mohammad-bashir@uiowa.Edu].
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Literature: transcatheter mitral valve-in-valve explant: lessons learned.
 
Manufacturer Narrative
As reported in a research article, transcatheter mitral valve-in-valve explant: lessons learned.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC¿ VALVE (MITRAL)
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key19098059
MDR Text Key340041061
Report Number2135147-2024-01672
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberE100-29M
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/18/2024
Initial Date FDA Received04/12/2024
Supplement Dates Manufacturer Received04/19/2024
Supplement Dates FDA Received04/30/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age71 YR
Patient SexMale
-
-